相关实验视频
Updated: Aug 13, 2026

04:53
An In Vitro Approach to Photodynamic Therapy
Published on: August 17, 2018
8.9K
用于光动力学治疗的活性增强剂
Maciej Michalak1,2, Jakub Szymczyk1, Aleksandra Pawska1,2
1Chair and Department of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.
Molecules (Basel, Switzerland)
|July 12, 2025
概括
纳米技术通过改善等光敏剂来增强光动力疗法 (PDT). 纳米载体克服了PDT的局限性,显示了癌症和抗菌治疗的前景.
科学领域:
- 生物医学工程 生物医学工程
- 纳米医学是一种纳米医学.
- 摄影化学的使用.
背景情况:
- 光动力疗法 (PDT) 是一种临床治疗癌症和感染的方法.
- 目前的PDT面临的挑战包括光敏剂溶解度差,光透度有限,瘤缺氧等.
- 是具有临床意义的光敏化剂.
研究的目的:
- 审查使用纳米技术来增强基于的光动力学疗法的进展.
- 探索纳米载体策略,以提高PDT的疗效和减少副作用.
- 讨论瘤学和抗微生物光动力疗法 (aPDT) 的应用.
主要方法:
- 关于提供的纳米载体系统的文献综述.
- 对各种纳米载体类型的分析:基于脂质的,基于聚合物的和基于碳的.
- 检查纳米载体增强PDT和aPDT的体外和体内研究.
主要成果:
- 纳米载体显著改善的特性,如溶解性和准性.
- 不同的纳米载体平台 (脂质体,体,氧化石墨烯等) 显示潜力. 展示潜力. 显示潜力.
- 纳米载体增强的在癌症和多药物耐药细菌的临床前模型中显示出有效性.
结论:
- 纳米技术提供了有效的解决方案,以克服光动力疗法的关键局限性.
- 基于纳米载体的素对改善癌症治疗和对抗抗菌素耐药性具有显著的前景.
- 需要进一步的临床转化才能充分实现纳米载体增强PDT的潜力.
相关概念视频
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Adrenergic Agonists: Therapeutic Uses
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...

